Who Paid My Doc
Praxbind
Drug Cardiovascular
NDC 0597-0197-05
General payments
$70,986
Research payments
$0
Through program year 2022, $70,986 in general payments and $0 in research payments were reported against Praxbind (Cardiovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $42 | 3 |
| 2021 | General | $1,876 | 13 |
| 2020 | General | $12,678 | 390 |
| 2019 | General | $56,390 | 1,126 |
Breakdown
Each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2022 where a state was reported.
Records
1,532 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.